Quick answers
- What is RyVent?
- RyVent is a brand name of Carbinoxamine maleate, a prescription medicine. The FDA NDC Directory lists 1 RyVent product in 1 strength and form.
- Who makes RyVent?
- Pharmobedient holds the FDA application for RyVent (ANDA207484, approved May 31, 2016).
- Is there a generic or store brand of RyVent?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a RyVent product, 3 of them generic. Ask your pharmacist whether one is right for you.
- Has RyVent been recalled?
- No recall linked to RyVent products (by their NDC code or label) appears in the FDA enforcement reports we use.
What RyVent is
Each RyVent product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Carbinoxamine maleate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| carbinoxamine maleate 6 mg tablet (oral) | RyVent | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Carbinoxamine maleate →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA207484 | Pharmobedient | May 31, 2016 | 1 |
Companies that list RyVent
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of RyVent products.
Recalls
No recall linked to RyVent products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.